August 2023 FDA Recall Drug by Hua Da Trading, Inc. Dba Wefun Inc.
D-1180-2023 - Marketed Without an Approved NDA/ANDA

This Class I drug recall was voluntarily initiated by Hua Da Trading, Inc. Dba Wefun Inc. on August 25, 2023 for the product Drug. The FDA reported the reason for recall as marketed without an approved nda/anda. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1180-2023

Reason for Recall
Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil, an ingredient found in a FDA approved product for the treatment of male sexual enhancement, making this an unapproved drug.
Initiated
08-25-2023
Reported
09-20-2023
Quantity
300 cartons

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Hua Da Trading, Inc. dba Wefun Inc.
Distributed Nationwide in the USA
WEFUN Capsules 825 mg, 1x10 blister pack per carton, Manufactured by WEFUN Brooklyn NY 11204 www.eshoponlineusa.com Bar Code X00358V0O5

Batch or Lot Expiration Information

Lot# #18520168, Exp. date 09/30/2026 .